The Hong Kong-based venture is developing an asset-light, technology-driven approach to private blood banking, supported by patent-pending intellectual property, specialist clinical expertise and early interest from prospective clients.
HONG KONG – November 18, 2026 – MiCells Limited (MiCells®), a Hong Kong-based healthcare technology startup developing private autologous blood banking solutions, has been selected for pre-incubation and acceleration support through an initiative involving China Resources Group and Hong Kong Science and Technology Parks Corporation (HKSTP). [Read more…]




